glp-1 drugs and fatty liver Why are agonists being used to treat patients with nonalcoholic disease? The GLP-1 Era: Why These
Description
This drug is currently in Phase 2 clinical trials
Glycaemic control typically improves within the first few weeks, whilst significant weight loss and associated energy improvements may take 3-6 months to become apparent
Accessed May 20, 2026
Conversely, CPA/EE showed a stronger effect to reduce androgens levels (99)
